05513nam a22005295i 4500001001800000003000900018005001700027007001500044008004100059020003700100024003500137050001400172072001700186072002300203072001600226245013000242250001800372264007200390300006400462336002600526337002600552338003600578347002400614490007000638505241700708520118003125650002604305650003104331650003004362650002304392650004004415650002504455650003204480650002304512650003004535700008204565710003404647773002604681776003604707776003604743776003604779830007704815856004604892912001404938912001404952999001704966978-981-97-4402-2DE-He21320251030113039.0cr nn 008mamaa240912s2024    si |    s    |||| 0|eng d  a97898197440229978-981-97-4402-27 a10.1007/978-981-97-4402-22doi 4aRC321-580 7aPSAN2bicssc 7aSCI0890002bisacsh 7aPSAN2thema10aRecent Advances and Challenges in the Treatment of Major Depressive Disorderh[electronic resource] /cedited by Yong-Ku Kim.  a1st ed. 2024. 1aSingapore :bSpringer Nature Singapore :bImprint: Springer,c2024.  aXXI, 426 p. 13 illus., 8 illus. in color.bonline resource.  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda1 aAdvances in Experimental Medicine and Biology,x2214-8019 ;v14560 aPart I. Molecular Biology-based Treatment for Depression -- Chapter 1. Neuroendocrinological Treatment Targets for Depressive Disorder -- Chapter 2. Psychophamacological Approaches for Neural Plasticity and Neurogenesis in Major Depressive Disorder -- Chapter 3. Efficacy, Safety and Tolerability of Psychedelics in Treatment Resistant Depression (TRD) -- Chapter 4. Probiotics and Fecal Microbiota Transplantation in Major Depression: Doxa or Episteme? -- Chapter 5. Induced Pluripotent Stem Cells (iPSC) Technology for Major Depression -- Chapter 6. Combining Complementary and Alternative Medicine (CAM) with Conventional Treatments for Major Depressive Disorder -- Part II. Brain Network-based Treatments for Depression -- Chapter 7. Application of Transcranial Direct and Alternating Current Stimulation (tDCS & tACS) on Major Depressive Disorder -- Chapter 8. Repetitive Transcranial Magnetic Stimulation (rTMS) in Major Depression -- Chapter 9. Deep Brain Stimulation (DBS) in Treatment-resistant Depression (TRD): Hope and Concern -- Chapter 10. Electroconvulsive Therapy (ECT) in Major Depression: Oldie but Goodie -- Part III. Psychological Intervention based Treatments for Depression -- Chapter 11. Cognitive Behavioral Therapy and Mindfulness-based Cognitive Therapy for Depressive Disorders: Enhancing Access and Tailoring Interventions in Diverse Settings -- Chapter 12. Acceptance and Commitment Therapy for Major Depressive Disorder: Navigating Depression Treatment in Traditional and Digital Settings with Insights from Current Research -- Chapter 13. The Importance of Psychotherapy for Treatment Resistant Depression -- Chapter 14. Personalized Well-Being Therapy (WBT) for Major Depression -- Part IV. Digital Psychiatry based Treatments for Depression -- Chapter 15. The Potential and Challenges of Virtual Reality as an Adjunctive Treatment of Depression Patients -- Chapter 16. The New Emerging Treatment Choice for Major Depressive Disorders: Digital Therapeutics -- Chapter 17. Telepsychiatry in the Treatment of Major Depressive Disorders -- Part V. Personalized Precision Treatments for Depression -- Chapter 18. Precision Medicine in Depression: The Role of Proteomics and Metabolomics in Personalized Treatment Approaches -- Chapter 19. Biomarker Guided Tailored Therapy in Major Depression -- Chapter 20. Navigating the Intersection of Technology and Depression Precision Medicine.  aThis book reviews all aspects of major depressive disorder (MDD), casting light on its neurobiological underpinnings and describing the most recent advances in management. The book is divided into four sections, the first of which discusses MDD from a network science perspective, highlighting the alterations in functional and structural connectivity and presenting insights achieved through resting state functional MRI and the development of neuroimaging-based biomarkers. The second section examines important diagnostic and neurobiological issues, while the third considers the currently available specific treatments for MDD, including biofeedback, neurofeedback, cognitive behavioral therapy, acceptance and commitment therapy, neuromodulation therapy, psychodynamic therapy, and complementary and alternative medicine. A concluding section is devoted to promising emerging treatments, from novel psychopharmacological therapies through to virtual reality treatment, immunotherapy, biomarker-guided tailored therapy, and more. Written by leading experts from across the world, the book will be an excellent source of information for both researchers and practitioners. 0aNeurosciences.968384 0aMedicinexResearch.962598 0aBiologyxResearch.965629 0aPhysiology.972764 0aClinical medicinexResearch.97412314aNeuroscience.96838624aBiomedical Research.96563324aPhysiology.97276424aClinical Research.9741241 aKim, Yong-Ku.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt9841942 aSpringerLink (Online service)0 tSpringer Nature eBook08iPrinted edition:z978981974401508iPrinted edition:z978981974403908iPrinted edition:z9789819744046 0aAdvances in Experimental Medicine and Biology,x2214-8019 ;v145696783140uhttps://doi.org/10.1007/978-981-97-4402-2  aZDB-2-SBL  aZDB-2-SXB  c63333d63333